NEET PG Question of the Day — 22 October 2026

Pharmacology · Antineoplastic Agents

22 Oct 2026PharmacologyAntineoplastic Agents

A 62-year-old male with a history of recurrent B-cell non-Hodgkin lymphoma is scheduled to begin a new targeted therapy regimen. The selected agent is a chimeric murine/human monoclonal IgG1 antibody that specifically binds to the CD20 surface antigen, inducing B-cell lysis through complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Which of the following drugs represents this specific monoclonal antibody?

Tap an option to check your answer.

New question every day
Attempt free
Explanations in the Kinase app

Ready to Start Practicing?

Start Free Practice

No credit card required